Technical Analysis for FLGT - Fulgent Genetics, Inc.

Grade Last Price % Change Price Change
grade C 5.08 -4.69% -0.25
FLGT closed down 4.69 percent on Monday, May 20, 2019, on 32 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical FLGT trend table...

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Inside Day Range Contraction -4.69%
Wide Bands Range Expansion -4.69%
Oversold Stochastic Weakness -4.69%
Wide Bands Range Expansion -9.45%
Lower Bollinger Band Touch Weakness -9.45%
Oversold Stochastic Weakness -9.45%
Doji - Bullish? Reversal -8.80%

Older signals for FLGT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.
Medicine Technology Biotechnology Cancers Genetics Medical Genetics Medical Tests Cardiovascular Diseases Neurological Disorders Molecular Diagnostics Applied Genetics Genetic Testing Qiagen Alternatives To Animal Testing
Is FLGT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.85
52 Week Low 3.02
Average Volume 17,230
200-Day Moving Average 4.4524
50-Day Moving Average 6.099
20-Day Moving Average 6.2578
10-Day Moving Average 5.5867
Average True Range 0.4171
ADX 32.63
+DI 11.8854
-DI 29.7049
Chandelier Exit (Long, 3 ATRs ) 6.5987
Chandelier Exit (Short, 3 ATRs ) 6.1913
Upper Bollinger Band 7.7168
Lower Bollinger Band 4.7988
Percent B (%b) 0.1
BandWidth 46.629806
MACD Line -0.2624
MACD Signal Line -0.1009
MACD Histogram -0.1615
Fundamentals Value
Market Cap 90.12 Million
Num Shares 17.7 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -6.77
Price-to-Sales 3.32
Price-to-Book 1.24
PEG Ratio 0.85
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.63
Resistance 3 (R3) 5.65 5.48 5.54
Resistance 2 (R2) 5.48 5.34 5.47 5.51
Resistance 1 (R1) 5.28 5.25 5.20 5.26 5.48
Pivot Point 5.11 5.11 5.07 5.10 5.11
Support 1 (S1) 4.91 4.97 4.83 4.90 4.68
Support 2 (S2) 4.74 4.88 4.73 4.65
Support 3 (S3) 4.54 4.74 4.62
Support 4 (S4) 4.53